Navigation Links
The world's largest heart failure congress -- Heart Failure Congress 2012
Date:3/20/2012

Sophia Antipolis, 20 March 2012: Four days of scientific sessions will be devoted to the latest advances and controversies in heart failure at this year's Heart Failure Congress 2012. The latest results from drugs and devices trials will be announced at the meeting.

Devices are one of the hottest topics in heart failure today and are the subject of this year's main theme, "Treatment of heart failure: integrating pharmacology and technology". Traditionally, heart failure has been treated with drugs and weight control, but the advent of novel devices including implantable cardioverter defibrillators (ICDs), cardiac resynchronisation therapy (CRT), left ventricular assist devices (LVADs) and telemedicine has revolutionised the field. "Pharmacology remains a fundamental part of management but extending it to include diagnostic technology, monitoring technology, and devices for treatment and management is of key importance," says Professor Piotr Ponikowski, President of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC).

Heart failure specialists and the media will also discuss emerging developments in the field including the new class of angiotensin receptor neprilysin inhibitors (ARNIs). Twenty-five years after the landmark CONSENSUS trial showed for the first time that ACE inhibitors prolong life in patients with heart failure, this session will tackle the question, "Are ACE inhibitors still the gold standard?".

Late-breaking abstracts are always popular and a great way to get news stories. This year they will be presented in three areas: clinical trials, basic and translational research, and clinical research. Journalists can expect new data on emerging mechanisms and therapies, and the latest results from drug trials and device trials. Abstracts are being submitted until 4 April to ensure that the congress gets a pick of the best and most up-to-date research.

New this year are two rapid fire sessions in which 16 abstracts will be briefly presented with Q&As to follow, a perfect format for journalists to pick up story ideas.

Sessions will be devoted to new devices for therapy and patient monitoring and controversies over when to use CRT (for example patients with atrial fibrillation or a narrow QRS). "There are subgroups of patients where it's controversial whether the benefit is there or not," says Professor Stefan D Anker, President-Elect of the HFA. "There is a big cost argument also. These devices don't come for free and of course many want to maximise the benefits to cost ratio when the number of devices they can implant is limited."

Held during 19-22 May 2012 at the Sava Center in Belgrade, Serbia, the congress is organised by the HFA in conjunction with the European Section of the International Society for Heart Research and the ESC Working Group on Myocardial Function. The collaboration has increased the focus on translational and basic science. "When you want to develop new therapies it's always important to have interactions with basic science because you need to look for new mechanisms and new targets," says Professor Anker.

The congress promises to be a rich source of news stories for journalists. The eagerly anticipated 2012 European guidelines for heart failure will be launched by Professor John JV McMurray (Glasgow, UK) on the first day. "This is going to be the premiere of the most important and relevant recommendations for all cardiologists on how to manage heart failure," says Professor Ponikowski.

Professor Gregory YH Lip (Birmingham, UK) will launch "Thromboembolism and antithrombotic therapy for heart failure in sinus rhythm", a consensus document from the HFA which has been endorsed by the ESC Working Group on Thrombosis. The document will be simultaneously published online in the European Journal of Heart Failure. It's a great chance for journalists to cover the latest advice on the timely issue of managing thromboembolic risk.

The Heart Failure Congress attracts cardiologists, internists, general physicians, basic scientists, epidemiologists, nurses and industry affiliates. For the first time at any of the ESC congresses there is an entire track of sessions in the local language (Serbo-Croatian). The sessions are expected to boost attendance from the Western Balkans and neighbouring countries. Professor Petar M Seferovic, Scientific Chairperson of the Congress, says: "This congress will be not only a historical cardiology event in the Western Balkans countries but also a prime medical gathering in this part of Europe."


'/>"/>

Contact: ESC Press Office
press@escardio.org
33-049-294-8627
European Society of Cardiology
Source:Eurekalert

Related medicine news :

1. Gunther von Hagens BODY WORLDS of Animals Opening March 19 at the Neunkirchen Zoo
2. Anthropologist: Body Worlds visitors confront bodies but not death
3. Losing Weight, Keeping It Off Can Be Two Different Worlds
4. EdenHome.com Adds Aventura Organic Clothes to Site and Announces Largest Online Selection of Stylish Organic Clothes for Men, Women and Children
5. Psychologists Say New Jerseys Largest Health Plan Violates Patient Privacy, Restricts Access to Care and Wastes Taxpayer Money
6. Biocell Center Corporation Partners with New Englands Largest Community-Based Hospital Network to Offer a Unique Service in Amniotic Fluid Stem Cell Preservation
7. DTM Systems Corporation Ranked Number One as the Largest Reseller in British Columbia to Hewlett Packard Canada
8. M. D. Anderson receives 4.5 million grant, largest ever for study of yoga and cancer
9. CA Dental Hygienists' Association to Provide Care to Thousands of Uninsured at Southland's Largest Free Public Health Clinic
10. Worlds largest polar science conference to take place in Oslo
11. Largest Internet Supplier of Eternity Rings Pledges 10% of their Profits to the National Breast Cancer Foundation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/10/2016)... ... 2016 , ... Denver-based humanitarian aid organization, Saving Moses, is ... , The situation in Syria continues to worsen—deadly weapon explosions are increasing as ... disease. The situation is intensifying with winter coming and airstrikes increasing. , ...
(Date:12/9/2016)... (PRWEB) , ... December 09, 2016 , ... Cellairis is ... and affordable repairs on iPhone , iPad and Samsung Galaxy devices ... Pearland Walmart in order to maximize convenience and accessibility for customers. While customers ...
(Date:12/9/2016)... ... December 09, 2016 , ... Sober College, ... with the grand opening of the Sober College Robert Pfeifer Memorial Learning Center ... December 2-3, and was attended by an overwhelming amount of alumni, family, colleagues ...
(Date:12/9/2016)... ... December 09, 2016 , ... MEDI+SIGN®, a provider of fully-automated ... new solution for Emergency Departments (ED) has been added to their portfolio. Housed ... examination rooms, and with a simplified pallet of information available to the patient, ...
(Date:12/8/2016)... ... December 08, 2016 , ... The Florida Hospital ... and Hyperbaric Medical Society (UHMS), the leading authority in hyperbaric medicine. This accreditation ... a few hospitals and facilities have earned this distinction. This is the second ...
Breaking Medicine News(10 mins):
(Date:12/9/2016)... DUBLIN , Dec 9, 2016 ... Optical Transceiver Market 2016-2020" report to their offering. ... The report forecasts the ... during the period 2016-2020. The report covers the ... market for 2016-2020. To calculate the market size, the report considers ...
(Date:12/9/2016)... Mitsubishi Tanabe Pharma Corporation (Head Office: ... Dr. Masayuki Mitsuka ) has presented data that ... intravenously in 10-14 day cycles for 48 weeks experienced ... Functional Rating Scale-Revised (ALSFRS-R). The data were presented at ... Dublin, Ireland . In ...
(Date:12/9/2016)... -- Research and Markets has announced the addition of ... offering. ... global travel vaccines market to grow at a CAGR of 6.83% ... scenario and the growth prospects of the global travel vaccines market ... revenue generated from the sales of various vaccines administered to actively ...
Breaking Medicine Technology: